The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Clinical trial NCT00002048 · COMPLETED
Trial details
- NCT number
- NCT00002048
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.